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A 16-Year Single-Center Experience
Scott J. Hoffman, MD,* David R. Holmes, JR, MD,* Alejandro A. Rabinstein, MD,†
Charanjit S. Rihal, MD,* Bernard J. Gersh, MD, DPHIL,* Ryan J. Lennon, MS,‡
iyaz Bashir, MD,§ Rajiv Gulati, MD, PHD*
Rochester, Minnesota; and Philadelphia, Pennsylvania
Objectives We sought to determine trends, predictors, in-hospital and long-term outcomes of cere-
brovascular events (CVE) related to percutaneous coronary intervention (PCI) over a 16-year period.
Background Despite a temporal increase in patient risk proﬁle and procedural complexity, rates of
PCI-related mortality and myocardial infarction have decreased. Temporal trends, characterization,
and outcomes after PCI-related CVE in the contemporary era remain unknown.
Methods We performed a retrospective study of 24,126 PCI hospitalizations in 19,165 unique pa-
tients, between January 1, 1994, and December 31, 2009, and compared those who suffered an in-
hospital PCI-CVE with the remaining control population who did not.
Results The incidence of CVE was 0.37% (n  89), of which 22% were transient ischemic attacks.
emporal analysis showed no signiﬁcant trend in incidence over 16 years (p  0.47). Multiple clini-
al and angiographic predictors of PCI-CVE were identiﬁed. Multivariate logistic regression analyses
evealed age, female sex, myocardial infarction within 7 days before PCI, and history of prior CVE as
ndependent predictors of PCI-CVE, with a 19-fold increase in incidence in patients over 80 with a
rior CVE history. In-hospital mortality was 19% after PCI-CVE versus 2% in controls (p  0.001).
Those who survived PCI-CVE exhibited a markedly higher risk of mortality over the subsequent 10
years (p  0.001).
Conclusions The incidence of PCI-related CVE has remained steady over a 16-year period, despite
an increase in the baseline risk proﬁle. Age and prior history of CVE were the strongest inde-
pendent demographic predictors. PCI-CVE had a markedly adverse impact on early and late
outcomes. (J Am Coll Cardiol Intv 2011;4:415–22) © 2011 by the American College of
Cardiology Foundation
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416Despite a progressive rise in the risk profile of patients
undergoing percutaneous coronary intervention (PCI), and
an increase in procedural complexity, temporal analyses have
indicated that PCI is getting safer (1,2). Studies have revealed
declines in mortality, myocardial infarction (MI), and a
variety of composite nonfatal major adverse cardiac events
over a 25-year period (1–3). From the patient standpoint,
the most-feared component of major adverse cardiac events
is stroke. Indeed, when asked to score a variety of future
scenarios, elderly patients rated the possibility of major
stroke as a fate worse than death (4).
A recent study from the National Cardiology Data
Registry reported that the incidence of procedural stroke in
all patients undergoing PCI between January 2004 and
March 2007 was 0.22% (5). Limitations of this study include
lack of independent adjudication of events and variation in
vent reporting between sites. Moreover, strokes with
ymptoms lasting 72 h without residual defects are not
ncluded in this registry. Thus, it seems likely that the
eported incidence is an underestimate. Two single-center
retrospective studies, covering a
period between January 1990 and
April 2002, reported a stroke in-
cidence of between 0.3% and
0.4% (6,7). The recent SYN-
TAX (Synergy Between Percuta-
neous Coronary Intervention with
Taxus and Cardiac Surgery) ran-
domized trial (8), comparing coro-
nary artery bypass grafting (CABG)
with multivessel or left main PCI,
indicated a stroke rate of 0.6% in
patients undergoing complex PCI.
Whether there has been a temporal
hange in the incidence of stroke as a complication of PCI
emains unknown. Increases in demographic risk profile,
isease burden, and procedural complexity might be ex-
ected to result in higher numbers of procedure-related
troke in the contemporary era, whereas this may be
ounterbalanced by the refinements in device technology
nd improvements in adjunctive pharmacology that have
lso occurred.
Factors previously found to be associated with the occur-
ence of PCI-related stroke include age, diabetes mellitus,
enal insufficiency, impaired left ventricular function, angio-
raphic burden of disease, and urgency of procedure (5–7).
lthough there are strong associations between PCI-related
troke and in-hospital and 1-year mortality (5,7), the
ong-term outcome of survivors of PCI-related stroke re-
ains unknown. In this large single-center registry study,
hich includes the contemporary era, we report temporal
rends, characteristics, predictors, and both short- and
ong-term outcomes of patients who suffer stroke or tran-
Abbreviations
and Acronyms
CABG  coronary artery
bypass grafting
CVE  cerebrovascular
event
IABP  intra-aortic balloon
pump
MI  myocardial infarction
PCI  percutaneous
coronary intervention
TIA  transient ischemic
attackient ischemic attack (TIA) as a complication of PCI. kMethods
Patient population. Patients undergoing PCI at the Mayo
Clinic in Rochester, Minnesota, are prospectively followed
in a registry that includes demographic, clinical, angio-
graphic, and procedural data. Immediate and in-hospital
events are recorded, and each patient is surveyed by tele-
phone using a standardized questionnaire at 6 months and
1 year, and then annually after the procedure. Ten percent
of all records are randomly audited by the supervisor for data
integrity. All adverse events are confirmed by reviewing the
medical records of the patients followed at our institution
and by contacting the patients’ physicians and reviewing the
hospital records of patients followed elsewhere.
In this study, all PCIs from January 1, 1994, to December
31, 2009, at this institution were eligible for analysis. For
patients with multiple PCIs within a single hospitalization,
only the first PCI of that hospitalization was included.
Patients who did not consent to use of their records for
research were excluded, as per Minnesota state statute.
There were 24,731 PCI hospitalizations of 19,657 unique
patients during this period. Four hundred ninety-two pa-
tients refused authorization of their records for research and
were excluded, leaving 24,126 hospitalizations for analysis.
These hospitalizations were divided into 2 groups for
analysis: 1) those who suffered an in-hospital cerebrovascu-
lar event (CVE) after PCI; and 2) those who did not.
Medical records of all patients were reviewed to determine
temporal trends, demographic and procedural characteris-
tics, and in-hospital and long-term outcomes of CVE
related to PCI.
Deﬁnitions. We defined CVE as any hemorrhagic stroke,
schemic stroke, or TIA related to PCI, based on detailed
etrospective chart review from January 1994 to December
009. Patients who underwent intervening CABG were
xcluded. Stroke was defined as any neurologic deficit
asting 24 h. Deficits of shorter duration were defined as
IA. All patients were evaluated by a consultant neurologist
t the time of the event and diagnosis was confirmed by
linical assessment. Additionally, brain imaging (computed
omography, magnetic resonance imaging, or both) was
btained in all but 1 patient. Where there was uncertainty as
o the relationship between the PCI procedure and neuro-
ogic event upon chart review, adjudication was performed
y an independent consultant neurologist (A.R.).
The number of diseased coronary arteries was defined by
he number of major arteries with at least 70% stenosis by
isual assessment. Patients with 50% stenosis in the left
ain coronary artery were considered to have 2-vessel
isease if there was right dominance and 3-vessel disease if
here was left dominance. Myocardial infarction was diag-
osed in the presence of 2 of the following 3 criteria: 1) typical
hest pain for at least 20 min; 2) elevation of serum creatine
inase levels (or the myocardial band fraction)2 normal;
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417and 3) a new Q-wave on the electrocardiogram. Severe renal
dysfunction was defined as a creatinine of 3.0 mg/dl or a
history of dialysis or renal transplant. Cardiogenic shock was
defined as a prolonged systolic arterial pressure95 mm Hg
while not on inotropes, intra-aortic balloon pump (IABP)
support, or systolic arterial pressure 110 mm Hg while on
inotropes or IABP support. Procedural success was defined
as a reduction of residual luminal diameter stenosis to
50% without in-hospital death, Q-wave MI, or need for
emergency CABG. In-hospital deaths included all deaths
during the index hospital admission. Prior history of CVE
was defined as a documented history of stroke or TIA that
resulted in abnormalities in vision, speech, sensation, or motor
function or a history of cerebrovascular (carotid) surgery.
Statistical analysis. Continuous variables are summarized as
mean  SD. Categorical variables are summarized as fre-
quency (percentage). Because multiple hospitalizations of
the same patient were included, a logistic regression model
with stroke complication as the end point was used to
compare risk factors between the 2 groups. Generalized
estimating equations were then employed to adjust the
inference for correlated observations. An autoregressive
correlation matrix within individual patients was assumed
such that procedures closer in time were more strongly
correlated. An Armitage trend test was used to test for an
increasing or decreasing trend in the incidence of stroke
complications over time. Odds ratios are used to describe
the magnitude of the association between stroke complica-
tions and age and prior history of stroke.
Multiple logistic regression was employed to assess asso-
ciations between patient and angiographic characteristics
with PCI-related CVE adjusted for other risk factors.
Variables that were associated with stroke at a 0.15 signif-
icance level before adjustment were included in the model,
with the following exceptions: urgency of PCI was excluded
because of its subjective nature and association with pre-
procedural MI; prophylactic IABP use was excluded be-
cause of its low incidence and its association with pre-
procedural shock; number of segments treated was excluded
because of its association with number of vessels treated.
These exclusions were chosen before fitting the model. No
other variable selection methods were employed. General-
ized estimating equations were used to adjust for correlated
observations within individuals.
Kaplan-Meier methods were used to estimate post-
discharge survival in patients who underwent PCI up to
December 31, 2008. Remaining patients to December 31,
2009, were not eligible for long-term analysis. Patients who
died before discharge were excluded. The log-rank test was
used to compare survival between patients who did and did
not have a post-PCI stroke complication. Cox proportional
hazards models were used to estimate the partial effect of
stroke on follow-up mortality after adjusting for other risk
factors. Variables that were significantly different betweenstroke and nonstroke patients were included as covariates in
the model. Adherence to the proportional hazards assump-
tion was assessed visually for each variable via a plot of
Schoenfeld residuals over time with a scatter plot smoother.
Variables that violated the assumption of proportional
hazards were modeled with time-dependent variables to
allow for varying effects.
Results
Incidence and type of CVE. Among 24,126 PCI hospitaliza-
tions between 1994 and 2009, the overall incidence of CVE
was 0.37% (n 89), of which 78% were strokes (deficit24
h) and 22% TIAs (deficit 24 h). Of all CVEs, 92% were
ischemic, 7% were hemorrhagic, and 1% unknown (no imaging).
Temporal trends. Temporal analysis indicated no significant
rend in the yearly incidence of PCI-related CVE between
994 and end 2009 (p  0.47). To adjust for changes in
atient demographics over time, independent predictors of
CI-related CVE identified by multivariate analysis were
sed to generate a risk-model for PCI-related CVE. There
ppeared to be a temporal reduction in the risk-adjusted
ncidence of PCI-related CVE over 16 years, although this
rend did not achieve statistical significance (Fig. 1).
Clinical features at presentation. The most frequently oc-
curring clinical features at presentation were limb motor
weakness (49%), speech impairment (39%), visual distur-
bance (20%), and facial droop (18%), among a variety of
symptoms and physical signs. Unresponsiveness was present
in 12% (Fig. 2A). The neurovascular distribution of non-
hemorrhagic events was determined by clinical evaluation
and brain imaging (computed tomography or magnetic reso-
nance imaging were obtained in 88 of 89 patients). The
majority of ischemic CVEs were confined to the anterior
Figure 1. Yearly Incidence of PCI-Related CVE
Temporal trend analysis indicates no statistically signiﬁcant change in the
incidence of percutaneous coronary intervention (PCI)-related cerebrovascu-
lar events (CVEs) between January 1994 and December 2009 after risk
adjustment (p  0.35, dashed lines represent conﬁdence intervals).
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418circulation (56%), with 24% in the posterior circulation and
13% occurring in both anterior and posterior distributions
(Fig. 2B). Of the 6 hemorrhagic events, 2 were in the anterior
circulation, 2 in the posterior circulation, and 2 were diffuse.
Patient characteristics. Demographic and baseline charac-
eristics of patients who suffered CVEs after PCI and the
emaining controls are outlined in Table 1. Patients who
Figure 2. Characteristics of CVEs Occurring After PCI
(A) Symptoms and signs of neurologic event at diagnosis are charted by frequ
features at presentation. (B) Vascular distribution of ischemic strokes occurring
magnetic resonance imaging. The majority were anterior-circulation events. Of
cular territories. Abbreviations as in Figure 1.
Table 1. Baseline Patient Characteristics
Variable
Controls
(n  24,037)
Post-PCI Stroke
(n  89) p Value
Age, yrs 66.4 12.1 73.7 10.7 0.001
Male 17,005 (71%) 44 (49%) 0.001
Body mass index, kg/m2 29.6 5.7 28.5 5.0 0.063
Unstable angina 14,246 (59%) 46 (52%) 0.15
MI within 7 days prior 7,638 (32%) 53 (60%) 0.001
History of MI, 7 days 7,583 (32%) 19 (22%) 0.038
Pre-procedural shock 909 (4%) 10 (11%) 0.001
CHF status 0.11
Never 19,343 (84%) 64 (78%)
Previous 1,047 (5%) 4 (5%)
Current 2,616 (11%) 14 (17%)
History of cholesterol 240 mg/dl 16,940 (77%) 64 (81%) 0.40
Peripheral vascular disease 2,700 (11%) 16 (18%) 0.052
History of CVE 2,652 (11%) 27 (32%) 0.001
Diabetes 6,114 (26%) 27 (31%) 0.27
Moderate-to-severe renal disease 892 (4%) 7 (8%) 0.046
Tumor/lymphoma/leukemia 2,917 (12%) 10 (11%) 0.78
Metastatic cancer 218 (1%) 1 (1%) 0.83
EF 40% 2,366 (10%) 13 (15%) 0.14
Values are expressed as mean SD or n (%).
CHF congestive heart failure; CVE cerebrovascular accident; EF ejection fraction;cMImyocardial infarction; PCI percutaneous coronary intervention.xperienced CVE were more likely to be older (age 74 11
ears vs. 66  12 years, p  0.001), women (51% vs. 29%,
 0.001), have a prior history of CVE (32% vs. 11%,
 0.001), have a history of hypertension (85% vs. 71%,
 0.007), have moderate-to-severe renal disease (8%
s. 4%, p  0.046), had cardiogenic shock before the
rocedure (11% vs. 4%, p  0.001), or have suffered a MI
ithin 7 days before PCI (60% vs. 32%, p  0.001).
Procedural characteristics. Angiographic and procedural
features associated with PCI-related CVE were compared
with the remaining controls and are outlined in Table 2.
PCI-related CVE was significantly associated with the
number of diseased vessels, number of segments treated, and
number of vessels treated. The urgency of PCI (elective vs.
urgent vs. emergent), presence of intracoronary thrombus,
and use of prophylactic IABP were also significant predic-
tors of CVE. Notably, the use of glycoprotein IIb/IIIa
agents did not influence the risk of CVE in this study.
Periprocedural low molecular weight heparin usage was
infrequent and did not differ between groups (6.7% PCI-
CVE vs. 4.6% controls, p 0.34). In addition, there was no
statistically significant difference in the rate of ischemic
stroke with radial versus femoral approaches (0.57% vs. 0.34%,
p  0.32).
Independent predictors of CVE. Multivariate logistic regres-
ion analysis was performed to determine the independent
redictors of in-hospital CVE after PCI (Table 3). Vari-
bles included in the model were age, sex, body mass index,
nstable angina, MI, pre-procedural shock, congestive heart
ailure at presentation, peripheral vascular disease, previous
VE, diabetes, moderate-to-severe renal disease, ejection
raction 40%, extent of vessel disease, presence of intra-
with motor weakness and speech impairment being the commonest clinical
PCI as determined by clinical evaluation and brain computed tomography/
a proportion of neurologic events involved both anterior and posterior vas-ency,
after
note,oronary thrombus, and multivessel intervention. Indepen-
e
c
a
a
h
i
w

o
1
w
s
W
(
(
a
r
D
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 4 , N O . 4 , 2 0 1 1 Hoffman et al.
A P R I L 2 0 1 1 : 4 1 5 – 2 2 PCI-Related CVE
419dent predictors of stroke were found to be age, female sex,
MI within 7 days before PCI, and previous CVE.
Analysis by age and prior history of stroke. Further analysis
according to age trends revealed that the incidence of CVE
increased as patients approached or surpassed 80 years
(p  0.001) (Fig. 3A). There was a 9-fold greater risk of
xperiencing a PCI-related CVE after the age of 80 years
ompared with 50 years, with the risk increasing sharply
fter age 70. This age effect was markedly amplified when
dditional stratification was performed according to prior
istory of CVE (Fig. 3B). This indicated a 19-fold increase
n the incidence of PCI-related CVE in patients 80 years
ith a preceding history of CVE, compared with those
50 years with no prior CVE history.
In-hospital outcomes. Procedural success of PCI was lower
in those who suffered CVE than in those who did not (70%
vs. 90%, p  0.001). Procedure-related MI, access-site
complications, parameters of hemodynamic disturbance,
usage of emergency IABP, requirement for emergent
CABG, and post-procedural renal failure were all signifi-
cantly more likely to occur in patients who suffered CVE
(Table 4). Moreover, in-hospital mortality was markedly
higher in the PCI-related CVE group compared with the
control group (19% vs. 2%, p  0.001). It is striking that
34% of the PCI-related CVE group suffered 1 or more of
in-hospital death, MI, CABG, or repeat PCI of the original
lesion compared with 7% of control patients (p  0.001).
Long-term outcomes. Survivors were followed for a median
Table 2. Angiographic and Procedural Characteristics
Variable
Controls
(n  24,037)
Post-PCI Stroke
(n  89) p Value
No. of diseased vessels (70/50) 0.025
Single 6,856 (30%) 18 (21%)
Double 8,596 (38%) 32 (37%)
Triple 6,469 (29%) 34 (40%)
Thrombus in any lesion 6,898 (31%) 43 (55%) 0.001
Prophylactic IABP 522 (2%) 5 (6%) 0.033
Urgency of PCI 0.001
Elective 8,509 (35%) 21 (24%)
Urgent 11,055 (46%) 32 (36%)
Emergency 4,459 (19%) 36 (40%)
No. of segments treated 1.5 0.7 1.7 0.8 0.001
Total no. vessels treated 0.080
1 20,538 (85%) 70 (79%)
2 3,261 (14%) 18 (20%)
3 231 (1%) 1 (1%)
Total no. of stents placed 1.3 1.0 1.3 1.2 0.71
GP IIb/IIIa use 11,688 (49%) 46 (52%) 0.57
Vein graft intervention 2,111 (9%) 9 (10%) 0.66
Values are expressed as n (%) or mean SD.
GP IIb/IIIa glycoprotein IIb/IIIa inhibitor; IABP intra-aortic balloon pump; other abbrevia-
tions as in Table 1.f 7.6 years after hospitalization (interquartile range 4.0 to1.4 years). In unadjusted Kaplan-Meier analyses, patients
ho suffered PCI-related CVE exhibited worse long-term
urvival than control patients did (both p  0.001) (Fig. 4A).
hen adjustment was performed for confounding factors
incorporating all possible predictors with p  0.15), long-
term survival after PCI-related CVE remained significantly
worse compared with non-CVE control patients (p  0.01)
Fig. 4B). Somewhat surprisingly, there did not appear to be
difference in long-term survival between those who expe-
ienced a TIA versus a stroke (Fig. 4C).
iscussion
Despite progressive declines in PCI-related mortality and
MI in the setting of higher-risk patient demographics (1,2),
as well as an increase in rates of PCI procedural success (3),
the current study indicates that the incidence of PCI-related
CVE has remained steady over a 16-year period, with an
overall incidence of 0.37%. Other important findings in-
clude the very strong association of age and previous CVE
history with risk of experiencing a PCI-related CVE, high
rates of in-hospital mortality, and markedly adverse long-
term outcomes in those who survive.
Demographic features associated with PCI-related CVE
in this and other studies (6,7) are also associated with
atherosclerotic disease burden. This likely underlies the
cause of PCI-related CVE in many cases. For example, the
presence of aortic plaque, particularly if mobile, is associated
Table 3. Independent Predictors of CVE After PCI
Label
Odds Ratio
(95% Confidence Interval) p Value
Age, per decade 1.47 (1.18–1.83) 0.0005
Male 0.55 (0.35–0.86) 0.0087
BMI, per 5 kg/m2 0.98 (0.81–1.19) 0.8619
Unstable angina 1.02 (0.66–1.59) 0.9238
MI within 7 days prior 2.18 (1.25–3.81) 0.0061
History of MI, 7 days 0.63 (0.35–1.14) 0.1259
Pre-procedural shock 1.52 (0.76–3.06) 0.2383
CHF at presentation 0.72 (0.38–1.36) 0.3066
Hypertension 1.67 (0.88–3.14) 0.1137
Peripheral vascular disease 1.26 (0.70–2.29) 0.4382
History of CVE 2.66 (1.63–4.33) 0.0001
Moderate-to-severe renal disease 1.77 (0.77–4.08) 0.1825
Prior PCI 0.75 (0.43–1.30) 0.3006
EF 40% 1.34 (0.71–2.54) 0.3628
Number of diseased vessels 1.08 (0.80–1.46) 0.6025
Thrombus in any lesion 1.60 (0.96–2.68) 0.0734
Multivessel intervention 1.67 (1.00–2.78) 0.0518
Multiple logistic regression was employed to assess independent associations between patient
and angiographic characteristics with PCI-related CVE, adjusted for other risk factors. Age, female
sex, MI within 7 days before PCI, and previous stroke history were determined to be independent
predictors of PCI-CVE.BMI body mass index; other abbreviations as in Table 4.
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420with risk of catheter-induced embolization (9), and athero-
sclerotic debris derived from the aorta is a frequent finding
in catheter aspirates (10,11). Procedural complexity was also
associated with risk of CVE. Potential mechanisms under-
lying this association might include a greater propensity for
thrombus formation on devices, displacement of intracoro-
nary thrombus, air embolization, and a higher likelihood of
periprocedural hypotension resulting in cerebral hypoperfu-
sion. Given the increase in numbers and proportion of PCI
procedures being performed in higher-risk populations
(1,2), it is perhaps reassuring that the rate of PCI-related
CVE has not increased in parallel. One can speculate that
improvements in device technology and pharmacological ther-
Figure 3. Incidence of CVE After PCI by Age and Previous History of Strok
(A) Risk of PCI-CVE by age. Incidence of CVE increases with age (p  0.001 for
history of stroke. Marked increase in the incidence of CVE in elderly patients w
describe the magnitude of the association between stroke complications and
Table 4. In-Hospital Outcomes
Variable
Controls
(n  24,037)
Post-PCI Stroke
(n  89) p Value
Procedural success 21,558 (89.7%) 62 (69.7%) 0.001
Death 434 (1.8%) 17 (19.1%) 0.001
Any MI 1,101 (4.6%) 16 (18.0%) 0.001
Q-wave MI 78 (0.3%) 1 (1.1%) 0.22
In-hospital CABG 251 (1.0%) 4 (4.5%) 0.004
In-hospital death/MI/CABG/TVR 1,771 (7.4%) 30 (33.7%) 0.001
Emergency use of IABP 532 (2.2%) 9 (10.1%) 0.001
Arterial thrombosis 18 (0.1%) 1 (1.1%) 0.008
Femoral bleed 215 (0.9%) 3 (3.4%) 0.022
Hematoma 799 (3.3%) 7 (7.9%) 0.022
Cardiac arrest 323 (1.3%) 10 (11.2%) 0.001
Shock 583 (2.4%) 9 (10.1%) 0.001
Heart block 296 (1.2%) 5 (5.6%) 0.001
Renal failure 256 (1.1%) 6 (6.7%) 0.001
Values are expressed as n (%).
CABG coronary artery bypass grafting; TVR target vessel revascularization; other abbrevi-ations as in Tables 1 and 2.apy have tempered this potential rise. In this regard,
progressive reductions in the profile of balloons and stents
over time have enabled the use of smaller-diameter guiding
catheters for device delivery. Compared with their larger-
diameter counterparts, smaller-caliber guides might be less
likely to disrupt atheroma from the aortic wall (10). Im-
provements in antiplatelet pharmacotherapy, with increased
use, and the widespread implementation of statin therapy
over the past 15 years might also be expected to favor a
reduction in procedural CVE via plaque stabilization and
antithrombotic mechanisms.
Although the incidence of PCI-related CVE is compa-
rable to historic single-center studies (6,7), the proportion
of hemorrhagic strokes in the current study is considerably
lower. A study from the National Cardiology Data Registry
comprising a more contemporary population did not distin-
guish between ischemic and hemorrhagic strokes (5), and as
such, it remains unclear whether the lower hemorrhagic
rates in our study reflect a reduction over time or a variation
in practice patterns, such as the infrequent administration of
fibrinolytic therapy and low molecular weight heparins in
our patient population.
The data suggest that outcomes after PCI-related CVE
are poor. In line with historic studies (6,7), in-hospital
complications were markedly more frequent than for control
patients and included procedural failure, MI, severe hemo-
dynamic disturbance, emergency CABG, and access-site
complications. Given this, the high rate of in-hospital
mortality (19.1%) may be less surprising. Of note, nearly all
in-hospital deaths occurred in patients who suffered a
significant neurologic deficit, with only 1 death occurring in
a patient who had a procedural TIA. The TIA patient
rend), particularly after age 70 years. (B) Risk of PCI-CVE by age and prior
prior history of stroke. The p values are based on odds ratios employed to
d prior history of stroke. Abbreviations as in Figure 1.e
age t
ith aexperienced no other complications, but developed unher-
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421alded pulseless electrical activity 2 days after PCI for an
acute coronary syndrome.
Survivors of PCI-related CVE also appeared to experi-
ence a long-term mortality disadvantage. This disadvantage
persisted even after adjustment for confounding factors.
Although this could be attributed to presence of unmea-
sured confounders, another explanation might be the higher
risk of developing life-threatening noncardiac morbidities
(e.g., pneumonia, deep vein thrombosis) that occur after in
CVE survivors.
In the current study, the 2 most powerful independent
predictors of CVE were age and prior history of CVE, with
the rate of procedural CVE approaching 2% in patients over
80 years with a prior history of stroke. This perhaps
underscores the importance of considering demographic
characteristics when assessing procedural risk and obtaining
informed consent. Although many of the risks for the
development of PCI-related CVE are not modifiable, it
would appear prudent to ensure optimal pharmacological
therapy, minimize guiding catheter diameters, and take
measures to avoid procedural hypotension particularly in
higher-risk patient subgroups such as these. Again, al-
though it remains to be determined whether newer device
technologies designed to deflect or capture displaced em-
bolic material will prove effective, future studies targeted
toward high-risk populations such as those identified here
would seem reasonable. Given the volume of diagnostic and
interventional cardiac catheterization procedures performed,
it is likely that thousands of CVE complications occur
annually in the U.S. alone (12). Moreover, projected in-
creases in the use of structural interventions such as trans-
cutaneous aortic valve replacement might further increase
rates of CVE related to cardiac catheter-based procedures.
The current study, indicating adverse short- and long-term
outcomes after such complications, underscores the impor-
tance of developing risk scores to identify groups at higher
risk in advance to facilitate timely implementation of treat-
ment measures such as early fibrinolysis (12) or acute
neuro-endovascular intervention when appropriate (13).
Study limitations. The present study is a retrospective anal-
sis from a single institution, which might limit its broad
pplication. Concurrent pharmacological therapy, measures
f risk-factor control, and presence of atrial fibrillation
ould have influenced CVE risk and were not available for
he study population. National Institutes of Health Stroke
cale assessment was not available for a significant number
f patients, such that stratification of outcome by degree of
mpairment was not possible. Although records were scru-
inized to ensure that all events included were appropriate,
t is possible that several CVEs went unrecognized (non-
pecific symptoms, brief duration, occurrence of sudden
eath without post-mortem evaluation), thereby underesti-
ating the true incidence. Moreover, as has recently beenFigure 4. Long-Term Outcomes After PCI-Related CVE by
Kaplan-Meier Analysis
(A) Kaplan-Meier estimate for survival. (B) After adjustment for con-
founding factors, incorporating all predictors with p  0.15, PCI-CVE is
independently associated with lower long-term survival. (C) Stratiﬁca-
tion by stroke (duration of event 24 h) versus transient ischemic
attach (TIA) (duration 24 h) indicates no difference in long-term sur-
vival between the 2 groups, suggesting that even a transient neurologic
event after PCI confers a survival disadvantage. NS  not signiﬁcant;escribed with transcatheter aortic valve implantation (14),
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422it is highly likely that clinically silent cerebral embolic events
also occur with PCI, and these would not have been recorded
in our study.
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